The association of metformin use with keratinocyte carcinoma development in high‐risk patients-Reference-Cited by-同舟云学术

The association of metformin use with keratinocyte carcinoma development in high‐risk patients

Author:

Misitzis Angelica¹²³^ORCID,Stratigos Alexander J.²,Beatson Meghan¹³⁴,Mastorakos George⁵,Dellavalle Robert P.⁶⁷⁸,Weinstock Martin A.¹³,

Affiliation:

1. Center for Dermatoepidemiology Providence VA Medical Center Providence Rhode Island USA

2. 1st Department of Dermatology and Venereology National and Kapodistrian University of Athens, A. Syggros Hospital Athens Greece

3. Department of Dermatology Brown University Providence Rhode Island USA

4. George Washington University School of Medicine Washington District of Columbia USA

5. Unit of Endocrinology, Diabetes mellitus and Metabolism 2nd Department of Obstetrics and Gynecology Athens Greece

6. School of Medicine University of Colorado Denver Aurora Colorodo USA

7. Dermatology Service, US Department of Veterans Affairs Denver Colorodo USA

8. Department of Dermatology University of Colorado School of Medicine Aurora Colorodo USA

Funder

Health Services Research and Development

Publisher

Wiley

Subject

Dermatology,General Medicine

Link

Reference12 articles.

1. Keratinocyte carcinoma mortality in the United States as reported in death certificates, 2011–2017;Misitzis A;Dermatol Surg,2019

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

4. Metformin use and keratinocyte carcinoma risk;Journal of the American Academy of Dermatology;2021-10